Kernodle & Katon Asset Management Group’s Pulse Biosciences PLSE Stock Holding History

Kernodle & Katon Asset Management Group’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$17K	Buy	+820	New	+$11.2K	0.01%	205

Other funds holding PLSE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Kernodle & Katon Asset Management Group's PLSE Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group opened a new position in Pulse Biosciences (PLSE) in Q1 2017: 820 shares worth $17K. The stake represents 0.01% of the portfolio and ranks #205 among its holdings.

29 funds tracked by Wall St. Rank hold PLSE as of Q1 2017.

Kernodle & Katon Asset Management Group held 820 shares of Pulse Biosciences worth $17K as of Q1 2017.
Pulse Biosciences was a new Kernodle & Katon Asset Management Group position in Q1 2017.
Pulse Biosciences made up 0.01% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #205 holding.
29 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.